Cargando…
Loganin Attenuates the Severity of Acute Kidney Injury Induced by Cisplatin through the Inhibition of ERK Activation in Mice
Cisplatin is the most widely used chemotherapeutic agent. However, it often causes nephrotoxicity, which results in acute kidney injury (AKI). Therefore, we urgently need a drug that can reduce the nephrotoxicity induced by cisplatin. Loganin is a major iridoid glycoside isolated from Corni fructus...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866969/ https://www.ncbi.nlm.nih.gov/pubmed/33572597 http://dx.doi.org/10.3390/ijms22031421 |
_version_ | 1783648196755456000 |
---|---|
author | Kim, Dong-Uk Kim, Dong-Gu Choi, Ji-Won Shin, Joon Yeon Kweon, Bitna Zhou, Ziqi Lee, Ho-Sub Song, Ho-Joon Bae, Gi-Sang Park, Sung-Joo |
author_facet | Kim, Dong-Uk Kim, Dong-Gu Choi, Ji-Won Shin, Joon Yeon Kweon, Bitna Zhou, Ziqi Lee, Ho-Sub Song, Ho-Joon Bae, Gi-Sang Park, Sung-Joo |
author_sort | Kim, Dong-Uk |
collection | PubMed |
description | Cisplatin is the most widely used chemotherapeutic agent. However, it often causes nephrotoxicity, which results in acute kidney injury (AKI). Therefore, we urgently need a drug that can reduce the nephrotoxicity induced by cisplatin. Loganin is a major iridoid glycoside isolated from Corni fructus that has been used as an anti-inflammatory agent in various pathological models. However, the renal protective activity of loganin remains unclear. In this study, to examine the protective effect of loganin on cisplatin-induced AKI, male C57BL/6 mice were orally administered with loganin (1, 10, and 20 mg/kg) 1 h before intraperitoneal injection of cisplatin (10 mg/kg) and sacrificed at three days after the injection. The administration of loganin inhibited the elevation of blood urea nitrogen (BUN) and creatinine (CREA) in serum, which are used as biomarkers of AKI. Moreover, histological kidney injury, proximal tubule damages, and renal cell death, such as apoptosis and ferroptosis, were reduced by loganin treatment. Also, pro-inflammatory cytokines, such as interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α, reduced by loganin treatment. Furthermore, loganin deactivated the extracellular signal-regulated kinases (ERK) 1 and 2 during AKI. Taken together, our results suggest that loganin may attenuate cisplatin-induced AKI through the inhibition of ERK1/2. |
format | Online Article Text |
id | pubmed-7866969 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-78669692021-02-07 Loganin Attenuates the Severity of Acute Kidney Injury Induced by Cisplatin through the Inhibition of ERK Activation in Mice Kim, Dong-Uk Kim, Dong-Gu Choi, Ji-Won Shin, Joon Yeon Kweon, Bitna Zhou, Ziqi Lee, Ho-Sub Song, Ho-Joon Bae, Gi-Sang Park, Sung-Joo Int J Mol Sci Article Cisplatin is the most widely used chemotherapeutic agent. However, it often causes nephrotoxicity, which results in acute kidney injury (AKI). Therefore, we urgently need a drug that can reduce the nephrotoxicity induced by cisplatin. Loganin is a major iridoid glycoside isolated from Corni fructus that has been used as an anti-inflammatory agent in various pathological models. However, the renal protective activity of loganin remains unclear. In this study, to examine the protective effect of loganin on cisplatin-induced AKI, male C57BL/6 mice were orally administered with loganin (1, 10, and 20 mg/kg) 1 h before intraperitoneal injection of cisplatin (10 mg/kg) and sacrificed at three days after the injection. The administration of loganin inhibited the elevation of blood urea nitrogen (BUN) and creatinine (CREA) in serum, which are used as biomarkers of AKI. Moreover, histological kidney injury, proximal tubule damages, and renal cell death, such as apoptosis and ferroptosis, were reduced by loganin treatment. Also, pro-inflammatory cytokines, such as interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α, reduced by loganin treatment. Furthermore, loganin deactivated the extracellular signal-regulated kinases (ERK) 1 and 2 during AKI. Taken together, our results suggest that loganin may attenuate cisplatin-induced AKI through the inhibition of ERK1/2. MDPI 2021-01-31 /pmc/articles/PMC7866969/ /pubmed/33572597 http://dx.doi.org/10.3390/ijms22031421 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kim, Dong-Uk Kim, Dong-Gu Choi, Ji-Won Shin, Joon Yeon Kweon, Bitna Zhou, Ziqi Lee, Ho-Sub Song, Ho-Joon Bae, Gi-Sang Park, Sung-Joo Loganin Attenuates the Severity of Acute Kidney Injury Induced by Cisplatin through the Inhibition of ERK Activation in Mice |
title | Loganin Attenuates the Severity of Acute Kidney Injury Induced by Cisplatin through the Inhibition of ERK Activation in Mice |
title_full | Loganin Attenuates the Severity of Acute Kidney Injury Induced by Cisplatin through the Inhibition of ERK Activation in Mice |
title_fullStr | Loganin Attenuates the Severity of Acute Kidney Injury Induced by Cisplatin through the Inhibition of ERK Activation in Mice |
title_full_unstemmed | Loganin Attenuates the Severity of Acute Kidney Injury Induced by Cisplatin through the Inhibition of ERK Activation in Mice |
title_short | Loganin Attenuates the Severity of Acute Kidney Injury Induced by Cisplatin through the Inhibition of ERK Activation in Mice |
title_sort | loganin attenuates the severity of acute kidney injury induced by cisplatin through the inhibition of erk activation in mice |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866969/ https://www.ncbi.nlm.nih.gov/pubmed/33572597 http://dx.doi.org/10.3390/ijms22031421 |
work_keys_str_mv | AT kimdonguk loganinattenuatestheseverityofacutekidneyinjuryinducedbycisplatinthroughtheinhibitionoferkactivationinmice AT kimdonggu loganinattenuatestheseverityofacutekidneyinjuryinducedbycisplatinthroughtheinhibitionoferkactivationinmice AT choijiwon loganinattenuatestheseverityofacutekidneyinjuryinducedbycisplatinthroughtheinhibitionoferkactivationinmice AT shinjoonyeon loganinattenuatestheseverityofacutekidneyinjuryinducedbycisplatinthroughtheinhibitionoferkactivationinmice AT kweonbitna loganinattenuatestheseverityofacutekidneyinjuryinducedbycisplatinthroughtheinhibitionoferkactivationinmice AT zhouziqi loganinattenuatestheseverityofacutekidneyinjuryinducedbycisplatinthroughtheinhibitionoferkactivationinmice AT leehosub loganinattenuatestheseverityofacutekidneyinjuryinducedbycisplatinthroughtheinhibitionoferkactivationinmice AT songhojoon loganinattenuatestheseverityofacutekidneyinjuryinducedbycisplatinthroughtheinhibitionoferkactivationinmice AT baegisang loganinattenuatestheseverityofacutekidneyinjuryinducedbycisplatinthroughtheinhibitionoferkactivationinmice AT parksungjoo loganinattenuatestheseverityofacutekidneyinjuryinducedbycisplatinthroughtheinhibitionoferkactivationinmice |